Amin Shahrbaf, M., Samimi, M., Karimi, S., Salari, M., Ghaffari, M., Yazdanbakhsh, S., Najafian, A., Vosough, M., & Massood Nabavi, S. (2024). The first study of real-world efficacy and safety of Natalizumab (Tysabri®) in Iran. Trends in Immunotherapy, 8(1). https://doi.org/10.24294/ti.v8.i1.3920